Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bayer Schering Pharma patents GLUT-1 inhibitors

Feb. 9, 2016

Piramal Enterprises discloses GPR120 agonists

Feb. 9, 2016

Bayer Schering Pharma presents antimitotic drugs

Feb. 8, 2016

Aurigene Discovery Technologies reports Nampt inhibitors

Feb. 8, 2016

ViiV Healthcare patents compounds to treat HIV infection

Feb. 8, 2016

Pfizer discloses phosphodiesterase 4B inhibitors

Feb. 8, 2016

Lupin divulges MEK inhibitors

Feb. 5, 2016

Zhejiang Kanglaite Group reports natural antitumor from Job's tears

Feb. 5, 2016

Pfizer describes TrKA inhibitors

Feb. 5, 2016

Innov17 develops ROR-alpha/ROR-gamma modulators

Feb. 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...